1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Cardiovasculares

Enfermedades Cardiovasculares

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Rodríguez Padial L, Barón-Esquivias G, Hernández Madrid A, Marzal Martín D, Pallarés-Carratalá V, de la Sierra A.

    Clinical Experience with Diltiazem in the Treatment of Cardiovascular Diseases.

    Cardiology and therapy . 5(1): 75-82. Nº de citas: 9

    [doi:10.1007/s40119-016-0059-1]

  • Assar ME, Angulo J, Santos-Ruiz M, de Adana JC, Pindado ML, Sánchez-Ferrer A, Hernández A, Rodríguez-Mañas L.

    Asymmetric dimethylarginine (ADMA) elevation and arginase up-regulation contribute to endothelial dysfunction related to insulin resistance in rats and morbidly obese humans.

    JOURNAL OF PHYSIOLOGY-LONDON . 594(11): 3045-3060. Nº de citas: 45

    [doi:10.1113/JP271836]

  • Aquila I, González A, Fernández-Golfín C, Rincón LM, Casas E, García A, Hinojar R, Jiménez-Nacher JJ, Zamorano JL.

    Reproducibility of a novel echocardiographic 3D automated software for the assessment of mitral valve anatomy.

    CARDIOVASCULAR ULTRASOUND . 14(1): 17-17. Nº de citas: 18

    [doi:10.1186/s12947-016-0061-8]

  • Franco E, Sánchez I, Moreno J.

    Challenging Lead Implantation Guided by Voltage Map.

    Revista espanola de cardiologia (English ed.) . 69(5): 516-516.

    [doi:10.1016/j.rec.2015.10.005]

  • Stockburger M, Defaye P, Boveda S, Stancak B, Lazarus A, Sipötz J, Nardi S, Rolando M, Moreno J.

    Safety and efficiency of ventricular pacing prevention with an AAI-DDD changeover mode in patients with sinus node disease or atrioventricular block: impact on battery longevity-a sub-study of the ANSWER trial

    EUROPACE . 18(5): 739-746. Nº de citas: 14

    [doi:10.1093/europace/euv358]

  • Martí D, Salido L, Mestre JL, Esteban MJ, Casas E, Jiménez-Mena M, Pey J, Sanmartín M, Hernández-Antolín R, Zamorano JL.

    Impact of thrombus burden on procedural and mid-term outcomes after primary percutaneous coronary intervention

    CORONARY ARTERY DISEASE . 27(3): 169-175. Nº de citas: 9

    [doi:10.1097/MCA.0000000000000317]

  • O'Donoghue ML, Glaser R, Cavender MA, Aylward PE, Bonaca MP, Budaj A, Davies RY, Dellborg M, Fox KA, Gutierrez JA, Hamm C, Kiss RG, Kovar F, Kuder JF, Im KA, Lepore JJ, Lopez-Sendon JL, Ophuis TO, Parkhomenko A, Shannon JB, Spinar J, Tanguay JF, Ruda M, Steg PG, Theroux P, Wiviott SD, Laws I, Sabatine MS, Morrow DA, LATITUDE-TIMI 60 Investigators.

    Effect of Losmapimod on Cardiovascular Outcomes in Patients Hospitalized With Acute Myocardial Infarction A Randomized Clinical Trial

    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION . 315(15): 1591-1599. Nº de citas: 149

    [doi:10.1001/jama.2016.3609]

  • Assar ME, Angulo J, Rodríguez-Mañas L.

    Diabetes and ageing-induced vascular inflammation

    JOURNAL OF PHYSIOLOGY-LONDON . 594(8): 2125-2146. Nº de citas: 59

    [doi:10.1113/JP270841]

  • Ferrari R, Aguiar C, Alegria E, Bonadonna RC, Cosentino F, Elisaf M, Farnier M, Ferrières J, Filardi PP, Hancu N, Kayikcioglu M, Mello E Silva A, Millan J, Reiner Ž, Tokgozoglu L, Valensi P, Viigimaa M, Vrablik M, Zambon A, Zamorano JL, Catapano AL.

    Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia.

    EUROPEAN HEART JOURNAL SUPPLEMENTS . 18(Suppl C): 2-12. Nº de citas: 52

    [doi:10.1093/eurheartj/suw009]

  • Cuadrado I, Saura M, Castejón B, Martin AM, Herruzo I, Balatsos N, Zamorano JL, Zaragoza C.

    Preclinical models of atherosclerosis. The future of Hybrid PET/MR technology for the early detection of vulnerable plaque.

    EXPERT REVIEWS IN MOLECULAR MEDICINE . 18: . Nº de citas: 13

    [doi:10.1017/erm.2016.5]

  • Martínez MA, Úbeda A, Moreno J, Trillo MÁ.

    Power Frequency Magnetic Fields Affect the p38 MAPK-Mediated Regulation of NB69 Cell Proliferation Implication of Free Radicals.

    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES . 17(4): 510-510. Nº de citas: 16

    [doi:10.3390/ijms17040510]

  • Fumagalli S, Chen J, Dobreanu D, Madrid AH, Tilz R, Dagres N.

    The role of the Arrhythmia Team, an integrated, multidisciplinary approach to treatment of patients with cardiac arrhythmias: results of the European Heart Rhythm Association survey.

    EUROPACE . 18(4): 623-627. Nº de citas: 19

    [doi:10.1093/europace/euw090]

  • Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL.

    [2015 ESC Guidelines for the management of infective endocarditis. The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)].

    Giornale italiano di cardiologia (2006) . 17(4): 277-319. Nº de citas: 33

    [doi:10.1714/2214.23904]

  • Caselli C, Prontera C, Liga R, De Graaf MA, Gaemperli O, Lorenzoni V, Ragusa R, Marinelli M, Del Ry S, Rovai D, Giannessi D, Aguade-Bruix S, Clemente A, Bax JJ, Lombardi M, Sicari R, Zamorano J, Scholte AJ, Kaufmann PA, Knuuti J, Underwood SR, Clerico A, Neglia D.

    Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina.

    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY . 36(4): 757-764. Nº de citas: 29

    [doi:10.1161/ATVBAHA.115.306818]

  • Escobar C, Abad-Cardiel M, Prieto MA, de la Figuera M, Barrios V, Segura J.

    Cambios en los objetivos terapéuticos y grado de control de la hipertensión arterial: nuevas evidencias.

    Hipertension y riesgo vascular . 33(2): 63-68.

    [doi:10.1016/j.hipert.2016.01.002]

  • Franco E, Muñoz DR, Matía R, Hernandez-Madrid A, Román AC, Sánchez I, Zamorano J, Moreno J.

    Wireless Ultrasound-Guided Axillary Vein Cannulation for the Implantation of Cardiovascular Implantable Electric Devices.

    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY . 27(4): 482-487. Nº de citas: 15

    [doi:10.1111/jce.12917]

  • Jimenez D, Lobo JL, Fernandez-Golfin C, Portillo AK, Nieto R, Lankeit M, Konstantinides S, Prandoni P, Muriel A, Yusen RD, PROTECT investigators.

    Effectiveness of prognosticating pulmonary embolism using the ESC algorithm and the Bova score.

    THROMBOSIS AND HAEMOSTASIS . 115(4): 827-834. Nº de citas: 20

    [doi:10.1160/TH15-09-0761]

  • Nicoll R, Wiklund U, Zhao Y, Diederichsen A, Mickley H, Ovrehus K, Zamorano P, Gueret P, Schmermund A, Maffei E, Cademartiri F, Budoff M, Henein M.

    The coronary calcium score is a more accurate predictor of significant coronary stenosis than conventional risk factors in symptomatic patients: Euro-CCAD study.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 207: 13-19. Nº de citas: 31

    [doi:10.1016/j.ijcard.2016.01.056]